Literature DB >> 10066346

Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes.

N Suzuki1, S Wakisaka, Y Takeba, S Mihara, T Sakane.   

Abstract

Cigarette smoking has been shown to affect human immune responses. We have studied Fas/Fas ligand (FasL) expression, which is involved in the cytotoxic activity, immune privilege, and self-tolerance, and other apoptosis-associated molecule expression of peripheral blood lymphocytes (PBL) in healthy subjects with/without cigarette smoking. We found that expression of FasL protein was detected marginally in the fresh PBL and was induced upon mitogen activation in normal individuals without smoking. In contrast, fresh PBL from those with chronic cigarette smoking exhibited enhanced expression of FasL protein without in vitro mitogen stimulation. Moreover, mitogen stimulation failed to augment FasL protein expression of their lymphocytes, suggesting dysregulation of FasL expression of PBL in individuals with cigarette smoking. In contrast, Fas, Bcl-2, and p53 expression were not significantly different between normal individuals with chronic cigarette smoking and those without smoking. In addition, we found that in vitro brief treatment with nicotine induces and/or enhances FasL mRNA and protein expression of lymphocytes from normal donors without smoking. These results suggest that aberrant FasL expression of lymphocytes is, at least in part, involved in the immune impairment in individuals with chronic cigarette smoking. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066346     DOI: 10.1006/cimm.1998.1432

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  Smoking and Liver Disease.

Authors:  Stephanie M Rutledge; Amon Asgharpour
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

Review 2.  Heavy smoking and liver.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

3.  Cigarette smoke affects apoptosis in rat tongue mucosa: role of bcl-2 gene family.

Authors:  Gerson F Assis; Daniele S Ceolin; Mariângela E A Marques; Daisy M F Salvadori; Daniel A Ribeiro
Journal:  J Mol Histol       Date:  2006-05-09       Impact factor: 2.611

4.  Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.

Authors:  Tao Liu; Li Zuo; Lin Li; Lei Yin; Kai Liang; Hongyuan Yu; Hui Ren; Wen Zhou; Hongwei Jing; Yang Liu; Chuize Kong
Journal:  Tumour Biol       Date:  2014-08-02

5.  Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.

Authors:  X Zhang; X Miao; T Sun; W Tan; S Qu; P Xiong; Y Zhou; D Lin
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

6.  Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Lisa M Marubio; Arthur L Beaudet; David L Jolkovsky; Kent E Pinkerton; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

7.  p53 expression in circulating lymphocytes of non-melanoma skin cancer patients from an arsenic contaminated region in Mexico. A pilot study.

Authors:  Ana M Salazar; Emma Calderón-Aranda; Mariano E Cebrián; Monserrat Sordo; Andrés Bendesky; Arístides Gómez-Muñoz; Leonor Acosta-Saavedra; Patricia Ostrosky-Wegman
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

8.  Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients.

Authors:  A El-Zayadi; Osaima Selim; H Hamdy; A El-Tawil; Hanaa-M Badran; M Attia; A Saeed
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

9.  Nicotine-mediated signals modulate cell death and survival of T lymphocytes.

Authors:  Silvia C S Oloris; Ashley A Frazer-Abel; Cristan M Jubala; Susan P Fosmire; Karen M Helm; Sally R Robinson; Derek M Korpela; Megan M Duckett; Shairaz Baksh; Jaime F Modiano
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-04       Impact factor: 4.219

10.  Hepatitis C comorbidities affecting the course and response to therapy.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.